Reported 10 months ago
The 2024 Tang Prize in Biopharmaceutical Science was awarded to scientists Joel F. Habener, Jens Juul Holst, and Svetlana Mojsov for their discovery of GLP-1 (7-37) as an insulinotropic factor and the development of anti-diabetic and anti-obesity drugs based on GLP-1 (7-37), benefiting millions worldwide. This recognition highlights their successful translation of basic research into pharmaceuticals, making significant contributions to human health by elucidating the role of GLP-1 (7-37), a gut hormone, in triggering insulin release and its therapeutic potential in diabetes and obesity treatment.
Source: YAHOO